Clinical Trial Update: The Vienna Prograf and Endothelial Progenitor Cell Extension Study [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update from Vienna on Prograf (tacrolimus) and endothelial progenitor cell extension, completed, focusing on immunosuppression and rena…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Immunosuppression
• Renal Failure

Drugs mentioned

• Prograf (Tacrolimus)

Snippet

Sponsor: Medical University of Vienna | Conditions: Immunosuppression, Renal Failure | Phase 4 | Status: COMPLETED